Clinical trial shows eptinezumab reduces headaches in adults with chronic migraine and medication-overuse headache, suggesting effective treatment options.
This clinical trial provides Class I evidence that eptinezumab with patient education is superior to placebo with patient education in reducing MMDs in adults with CM and MOH.
No takes yet. Share an insight, caveat, or question.
Jensen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: